- FDA Rules for Cigarettes Are a Victory for Public Health, for Science (and for the Earth’s Climate?)
- Legislation Introduced to Codify Stem Cell Rules
- Commissioner Enhances FDA’s Commitment to Personalized Medicine
- Perfecting Policy on Stem Cells
- NIH and FDA Aim to Retool Regulatory Science
- DOE Leads Federal Funding for a Regional Innovation Cluster
- Certainty on the Science of Climate Change
- They’re Not Perfect Cells, But They’re Model Cells
- Genomic Medicine on the March
- President’s Budget Aims to Recharge Regional Innovation
- Event: The Science of Climate Change
- Progress in Bioethics
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
Less Philosophy, More Policy: Obama Disbands Council on Bioethics and Will Create New One
Last week, the White House sent letters to the members of the President’s Council on Bioethics informing them that their services were no longer needed. According to a report today from Nicholas Wade in The New York Times, a spokesperson said that the mandate of a new council would be to offer “practical policy options,” in contrast to the work of the current council, which SP advisory board member Alta Charo told Wade “seemed more like a public debating society.”
There have been six bioethics advisory panels since 1974, and President George W. Bush convened the current council in November of 2001, a few months after announcing limitations on federal support for embryonic stem cell research. (For more context, see our “Timeline: A Brief History of Stem Cell Research.”)
Shortly after President Obama rescinded those restrictions, 10 of the 18 members of the existing council (whose charter would have expired in September), issued a statement criticizing the new policy. They claimed the new policy mischaracterized the Bush rules, which it did not; they claimed the old policy was advancing research within ethical norms, despite the fact it slowed research; and argued that the new policy did not address reproductive cloning, despite the fact NIH was tasked with tackling that question as it drafted guidelines. (More on that statement here.)
Another administration source indicates that the President is reviewing options for a new council with a revised, policy-focused mandate, but there is currently no public word on a timeframe.
Comments on this article


